Thanks @GCInvestor . Let's hope that publication can be expedited and brought forward from Q2 to Q1. FDA approval is a critical gateway to large-scale commercialisation for Neurotech.
But I'm not getting my hopes up too much. Commercialisation of the product will not be a priority for the Carrick Institute. They will be far more concerned about credibility and rigour, so they absolutely will not rush through preparation of the paper.
Our best hope is that the journal's editorial team will decide that the news is sufficiently important to warrant publication ahead of earlier submissions.
- Forums
- ASX - By Stock
- NTI
- anticipated results
anticipated results, page-40
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
7.3¢ |
Change
0.005(7.35%) |
Mkt cap ! $69.19M |
Open | High | Low | Value | Volume |
6.9¢ | 7.3¢ | 6.9¢ | $50.92K | 736.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19749 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.3¢ | 262651 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4597 | 0.069 |
2 | 191421 | 0.068 |
3 | 299790 | 0.067 |
2 | 162000 | 0.066 |
6 | 428930 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 262651 | 1 |
0.074 | 40000 | 1 |
0.075 | 888582 | 3 |
0.076 | 90000 | 1 |
0.077 | 150000 | 2 |
Last trade - 10.08am 09/09/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |